|
KMID : 1038620170350030289
|
|
Radiation Oncology Journal
2017 Volume.35 No. 3 p.289 ~ p.294
|
|
|
Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma
|
|
Kim Gwi-Eon
Song Hee-Sung
Ahn Ki-Jung
Kim Young-Suk
|
|
|
Abstract
|
|
|
|
Sorafenib is widely used for unresectable and metastatic hepatocellular carcinomas. Radiation recall dermatitis (RRD) is an acute inflammatory reaction confined to previously irradiated skin that occurs after the administration of certain drugs. RRD after sorafenib treatment is rare; five cases have been reported thus far. We describe a 44-year-old man irradiated for chest wall bone metastasis from hepatocellular carcinoma. Eight days after radiotherapy completion, systemic therapy for metastatic hepatocellular carcinoma was initiated with sorafenib treatment. Eleven days after starting sorafenib, the patient complained of erythematous rash with pruritus in the chest wall, in a location consistent with the previous radiation field. Sorafenib was continued at the same dose, despite the RRD. The skin reaction subsided over the next 2 weeks without any medical intervention.
|
|
|
KEYWORD
|
|
|
Sorafenib, Radiotherapy, Radiation recall dermatitis, Hepatocellular carcinoma
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|